BRUSSELS, Sept 14 (Reuters) – Kimberly-Clark is readying concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Trump dismisses AI safety alarm, says US already has tools to police industry
By Courtney Rozen and Katharine Jackson WASHINGTON, Sept 14 (Reuters) - President Donald Trump said…
Experts urge FDA to set clear safety and access standards for psychedelic drugs
By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - Doctors, veterans, pharmacists and therapists…
Coutinho joins Neymar at Santos on short-term deal
VIDEO SHOWS: ARCHIVE PHOTOS & FOOTAGE OF PHILIPPE COUTINHO SHOWS: SAO PAULO, BRAZIL (ARCHIVE –…
